BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 38735704)

  • 1. Pancreatic GHRHomas in Patients with or without Multiple Endocrine Neoplasia Type 1 (MEN 1) : An Analysis of 36 Reported Cases.
    Yamasaki R
    J Med Invest; 2024; 71(1.2):1-8. PubMed ID: 38735704
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Two different pituitary adenomas in a patient with multiple endocrine neoplasia type 1 associated with growth hormone-releasing hormone-producing pancreatic tumor: clinical and genetic features.
    Shintani Y; Yoshimoto K; Horie H; Sano T; Kanesaki Y; Hosoi E; Yokogoshi Y; Bando H; Iwahana H; Kannuki S
    Endocr J; 1995 Jun; 42(3):331-40. PubMed ID: 7670561
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A non-acromegalic case of multiple endocrine neoplasia type 1 accompanied by a growth hormone-releasing hormone-producing pancreatic tumor.
    Sugihara H; Shibasaki T; Tatsuguchi A; Okajima F; Wakita S; Nakajima Y; Tanimura K; Tamura H; Ishii S; Kamegai J; Akasu H; Kitagawa W; Shimizu K; Nakamura Y; Uchida E; Tajiri T; Naito Z; Katakami H; Oikawa S
    J Endocrinol Invest; 2007 May; 30(5):421-7. PubMed ID: 17598976
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acromegaly and somatotroph hyperplasia with adenomatous transformation due to pituitary metastasis of a growth hormone-releasing hormone-secreting pulmonary endocrine carcinoma.
    Nasr C; Mason A; Mayberg M; Staugaitis SM; Asa SL
    J Clin Endocrinol Metab; 2006 Dec; 91(12):4776-80. PubMed ID: 16968791
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acromegaly caused by growth hormone-relating hormone in a patient with multiple endocrine neoplasia type I.
    Liu SW; van de Velde CJ; Heslinga JM; Kievit J; Roelfsema F
    Jpn J Clin Oncol; 1996 Feb; 26(1):49-52. PubMed ID: 8551667
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A growth hormone-releasing hormone-producing pancreatic islet cell tumor metastasized to the pituitary is associated with pituitary somatotroph hyperplasia and acromegaly.
    Sanno N; Teramoto A; Osamura RY; Genka S; Katakami H; Jin L; Lloyd RV; Kovacs K
    J Clin Endocrinol Metab; 1997 Aug; 82(8):2731-7. PubMed ID: 9253362
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neuroendocrine tumors secreting growth hormone-releasing hormone: Pathophysiological and clinical aspects.
    Gola M; Doga M; Bonadonna S; Mazziotti G; Vescovi PP; Giustina A
    Pituitary; 2006; 9(3):221-9. PubMed ID: 17036195
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Pathophysiology and gene abnormalities of endocrine tumors].
    Saito S
    Nihon Naibunpi Gakkai Zasshi; 1992 Dec; 68(12):1225-39. PubMed ID: 1363316
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Loss of heterozygosity on chromosome 11q13 in two families with acromegaly/gigantism is independent of mutations of the multiple endocrine neoplasia type I gene.
    Gadelha MR; Prezant TR; Une KN; Glick RP; Moskal SF; Vaisman M; Melmed S; Kineman RD; Frohman LA
    J Clin Endocrinol Metab; 1999 Jan; 84(1):249-56. PubMed ID: 9920092
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ectopic growth hormone-releasing hormone (GHRH) syndrome in a case with multiple endocrine neoplasia type I.
    Yamasaki R; Saito H; Sano T; Kameyama K; Yoshimoto K; Hosoi E; Matsumura M; Harada K; Saito S
    Endocrinol Jpn; 1988 Feb; 35(1):97-109. PubMed ID: 2899505
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pituitary tumors and hyperplasia in multiple endocrine neoplasia type 1 syndrome (MEN1): a case-control study in a series of 77 patients versus 2509 non-MEN1 patients.
    Trouillas J; Labat-Moleur F; Sturm N; Kujas M; Heymann MF; Figarella-Branger D; Patey M; Mazucca M; Decullier E; Vergès B; Chabre O; Calender A;
    Am J Surg Pathol; 2008 Apr; 32(4):534-43. PubMed ID: 18300794
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Morphological characteristics of pituitary adenomas in the phenocopy of multiple endocrine neoplasia type 1].
    Trukhina DA; Mamedova EO; Lapshina AM; Vasilyev EV; Tiulpakov AN; Belaya ZE
    Probl Endokrinol (Mosk); 2021 Oct; 67(6):50-58. PubMed ID: 35018761
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Somatotroph hyperplasia. Successful treatment of acromegaly by removal of a pancreatic islet tumor secreting a growth hormone-releasing factor.
    Thorner MO; Perryman RL; Cronin MJ; Rogol AD; Draznin M; Johanson A; Vale W; Horvath E; Kovacs K
    J Clin Invest; 1982 Nov; 70(5):965-77. PubMed ID: 6290540
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ectopic acromegaly due to a pancreatic neuroendocrine tumor producing growth hormone-releasing hormone.
    Weiss DE; Vogel H; Lopes MB; Chang SD; Katznelson L
    Endocr Pract; 2011; 17(1):79-84. PubMed ID: 20713338
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gigantism in sibling unrelated to multiple endocrine neoplasia: case report.
    Matsuno A; Teramoto A; Yamada S; Kitanaka S; Tanaka T; Sanno N; Osamura RY; Kirino T
    Neurosurgery; 1994 Nov; 35(5):952-5; discussion 955-6. PubMed ID: 7838348
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Somatotrophinomas in multiple endocrine neoplasia type 1: a review of clinical phenotype and insulin-like growth factor-1 levels in a large multiple endocrine neoplasia type 1 kindred.
    Burgess JR; Shepherd JJ; Parameswaran V; Hoffman L; Greenaway TM
    Am J Med; 1996 May; 100(5):544-7. PubMed ID: 8644767
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ectopic secretion of growth hormone-releasing hormone (GHRH) in neuroendocrine tumors: relevant clinical aspects.
    Doga M; Bonadonna S; Burattin A; Giustina A
    Ann Oncol; 2001; 12 Suppl 2():S89-94. PubMed ID: 11762359
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical characteristics and outcome of acromegaly induced by ectopic secretion of growth hormone-releasing hormone (GHRH): a French nationwide series of 21 cases.
    Garby L; Caron P; Claustrat F; Chanson P; Tabarin A; Rohmer V; Arnault G; Bonnet F; Chabre O; Christin-Maitre S; du-Boullay H; Murat A; Nakib I; Sadoul JL; Sassolas G; Claustrat B; Raverot G; Borson-Chazot F;
    J Clin Endocrinol Metab; 2012 Jun; 97(6):2093-104. PubMed ID: 22442262
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of tumor characteristics and pre- and postoperative hormone levels on hormonal remission following endoscopic transsphenoidal surgery in patients with acromegaly.
    Cardinal T; Rutkowski MJ; Micko A; Shiroishi M; Jason Liu CS; Wrobel B; Carmichael J; Zada G
    Neurosurg Focus; 2020 Jun; 48(6):E10. PubMed ID: 32480366
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acromegaly caused by growth hormone releasing hormone (GHRH) secreting tumor in multiple endocrine neoplasia (MEN-1).
    Saleem TF; Santhanam P; Hamoudeh E; Hassan T; Faiz S
    W V Med J; 2012; 108(2):26-30. PubMed ID: 22655432
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.